However, Sp1 overexpression enabled the alteration of UPR signaling, particularly the attenuation of BA-induced activation of the PERK/CHOP axis, thereby reversing the inhibitory effects of BA on GBM cell growth. The gene discussed is EIF2AK3; the disease is glioblastoma.